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Abstract
Background: Meta-analysis has become increasingly popular in recent years, especially in genomic data analysis, due
to the fast growth of available data and studies that target the same questions. Many methods have been developed,
including classical ones such as Fisher’s combined probability test and Stouffer’s Z-test. However, not all meta-analyses
have the same goal in mind. Some aim at combining information to find signals in at least one of the studies, while
others hope to find more consistent signals across the studies. While many classical meta-analysis methods are
developed with the former goal in mind, the latter goal has much more practicality for genomic data analysis.
Results: In this paper, we propose a class of meta-analysis methods based on summaries of weighted ordered
p-values (WOP) that aim at detecting significance in a majority of studies. We consider weighted versions of classical
procedures such as Fisher’s method and Stouffer’s method where the weight for each p-value is based on its order
among the studies. In particular, we consider weights based on the binomial distribution, where the median of the
p-values are weighted highest and the outlying p-values are down-weighted. We investigate the properties of our
methods and demonstrate their strengths through simulations studies, comparing to existing procedures. In addition,
we illustrate application of the proposed methodology by several meta-analysis of gene expression data.
Conclusions: Our proposed weighted ordered p-value (WOP) methods displayed better performance compared to
existing methods for testing the hypothesis that there is signal in the majority of studies. They also appeared to be
much more robust in applications compared to the rth ordered p-value (rOP) method (Song and Tseng, Ann. Appl.
Stat. 2014, 8(2):777–800). With the flexibility of incorporating different p-value combination methods and different
weighting schemes, the weighted ordered p-values (WOP) methods have great potential in detecting consistent
signal in meta-analysis with heterogeneity.
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Background
Meta-analysis has long been used to integrate data
and/or results from multiple studies targeting the same
questions. It is commonly used in many areas of sta-
tistical applications such as clinical studies and psy-
chology experiments. In recent years, meta-analysis has
been frequently adopted in genomic data analysis, due
to the fast development of high-throughput technol-
ogy and the vast amounts of data available in public
databases.
Many meta-analysis methods have been developed
throughout the years. Roughly speaking, there are two
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main approaches to meta-analysis methods Song and
Tseng [1]. The first directly combines the p-values from
the studies, while the second attempts to model the data
or the effect sizes from the combined studies. The former
includes methods such as the Fisher’s combined prob-
ability test [2] and the Stouffer’s Z-test [3], as well as
weighted variations of these classical tests. The latter
includes a variety of fixed effects and random effects mod-
els, such as GeneMeta [4]. Each approach has its advan-
tages and disadvantages. The p-value combining methods
are relatively flexible in that they require minimal infor-
mation and assumptions from the studies. In this paper
we will mainly focus onmethods that directly combine the
p-values.
© 2014 Li and Ghosh; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
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Most of the traditional meta-analysis methods (e.g.
Fisher’s and Stouffer’s methods) aim at testing the alterna-
tive hypothesis that at least one of the studies is non-null.
While this aligns with earlier goals of meta-analyses to
gain power in detecting signals by combining multiple
studies, it is frequently not the case with genomic data. In
meta-analysis of genomic studies for example, the goal is
often to identify genes that are differentially expressed in a
consistent pattern across multiple studies. The extreme of
this would be to test for the alternative that the null can be
rejected for all the studies. A solution to this extreme alter-
native dates back to the maxP method by Wilkinson [5].
However, the maxP method is often considered too con-
servative. A recent approach by Phillips and Ghosh [6]
improves the power of testing for this disjunction of nulls
when the rejection of all p-values associated with a gene
is required. In practical meta-analyses, the goal of reject-
ing all studies may be considered too extreme. Ideally, we
would want to target at detecting consistent signals across
studies while avoiding being overly exclusive. This issue
has gained attention in recent years, and a number of
authors have tried to address this problem. Benjamini and
Heller [7] discussed a framework for testing partial con-
junction hypotheses, where they test for the alternative
that at least u out of n null hypotheses are false against the
partial conjunction null that no more than n−u+1 of the
null hypotheses are true. Song and Tseng [1] proposed the
rth ordered p-value (rOP) method that aims at testing the
alternative hypothesis that there is signal in at least a given
percentage of studies. Other methods exist that address
this problem from different approaches, such as RankProd
by Hong et al. [8] that looks for consistently highly ranked
genes, and a weighted approach by Li and Ghosh [9]
that weights genes by its expression consistency across
studies.
We consider the problem of detecting signals in the
majority of studies. Our approach adopts one aspect of
the rOP method Song and Tseng [1] in that we also
consider ordered p-values. But instead of using a sin-
gle rth ordered p-value as the statistic (as rOP does),
we combine all or a subset of the ordered p-values
while weighting them based on their order (weighted
ordered p-values, WOP). P-values closer to the median
are highly weighted and the smallest/largest p-values are
down-weighted. The idea is that among the collection
of p-values, the median p-values are likely to be a bet-
ter reflection of the behavior of the majority of studies
than the smallest or largest p-values. Olkin and Saner [10]
discussed a trimmed Fisher’s procedure that leaves out
a number of the smallest and/or largest p-values from
the calculation of Fisher’s statistic to remove the effect of
possible aberrant extremes. In our consideration, we still
keep the smallest/largest p-values because they do carry
certain information, but we down-weight them because
they may be relatively less relevant when considering
the “majority” of studies. To reflect the up-weighting of
the medians and down-weighting of the extremes, we
calculated our weights based on the binomial distribu-
tion. To summarize the weighted ordered p-values, we
mainly considered Fisher’s statistic and Stouffer’s Z-test.
We also explored some other statistics, such as gener-
alized Fisher’s test by Lancaster [11]. In general, other
summary statistics can be used under this framework as
well.
While many weighted variations of Fisher’s statistic
and Stouffer’s statistic have been developed throughout
the years, most of them distribute weights according to
the sample sizes and/or effect sizes of the studies, or
other similar considerations (e.g. Mosteller and Bush [12],
Won et al. [13], Makambi [14]). Li and Tseng [15] pro-
posed an interesting adaptively weighted statistic, where
the weights are used to maximize the significance of the
summary statistic. However, to the best of our knowl-
edge, none of the weighting schemes are based on the
ordered p-values, which is what makes our method
unique. Xie et al. [16] discussed a meta-analysis approach
using confidence distributions, where they incorporated
the use of medians and kernel functions, but their
approach is under a completely different framework from
ours.
By incorporating more than one order statistic into
our summary statistic, our method can be consid-
ered an expansion of the rth ordered p-value (rOP)
method Song and Tseng [1]. In general, both the rOP
method and the original summary statistic we use (e.g.
Fisher’s or Stouffer’s method) are special cases under the
WOP framework - one having all the weight on a single
ordered p-value and the other having evenly distributed
weights. However, our WOP methods have respective
advantages over both the traditional summary statis-
tics and the rOP method. Compared to the traditional
summary statistics, the WOP methods better focus on
detecting signal in a majority of studies. On the other
hand, the WOP methods appear to be more robust com-
pared to the rOP method. These observations are based
upon results from simulation studies as well as data
applications.
Methods
Hypothesis settings for meta-analysis
Before performing any meta-analysis, it is always impor-
tant to figure out the goal of combining multiple studies.
When a single hypothesis test is conducted, it is clear
what the null and alternative hypotheses are. In meta-
analysis we usually combine studies designed to test the
same set of null and alternative hypotheses. However,
the null and alternative hypotheses of the meta-analysis
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test are not always obvious and largely depends on the
researcher’s goals. Here we consider the example of meta-
analysis of differential expression studies of genomic data.
Sometimes a gene is of interest as long as it is differen-
tially expressed in at least one study, while other times
we hope to target genes that are differentially expressed
in all studies. Li and Tseng [15] and Song and Tseng [1]
both provided extensive discussions on the different sce-
narios that lead to different hypothesis settings. Following
their notation, let θgk be the true effect size for gene g
(1 ≤ g ≤ G) in study k (1 ≤ k ≤ K). As in Song and Tseng
[1], for a given 1 ≤ r ≤ K , a general hypothesis setting for







I(θgk =0)=0 versusH(r)a :
K∑
k=1
I(θgk =0) ≥ r
}
.
When r = 1, HS1 is the classical setting of test-
ing for non-zero effect size in at least one study against
the conjunction of nulls. HS1 is the hypothesis set-
ting that Fisher’s method, Stouffer’s Z-test and many
other traditional methods test for. When r = K , HSK
tests for the alternative that all the studies have non-
zero effect size. For instance, the maxP method [5]
tests for HSK . When 1 < r < K ,HSr provides a compro-
mise between the two aforementioned hypothesis set-
tings, and tests for at least a pre-specified number of
non-zero effects. For a given r, the rOP (rth ordered
p-value) method Song and Tseng [1] is used to test
for HSr .
In this paper, we test for non-zero effect sizes in a major-
ity of studies against the null that the effects sizes are zero
in all studies. Thus we are testing against the conjunction
of nulls while trying to focus on a certain subset of the
non-null space. In general, the hypothesis for our meta-
analysis approach can be considered to fall under the HSr
setting. Song and Tseng [1] suggested a few data-driven
methods for selecting r. To prevent any potential issues of
post hoc choices of r, we choose to fix r before any analy-
sis is conducted. While it is hard to specify what the term
“majority” exactly means, as a general rule, we choose to
test the hypothesis setting HSm, where m = K/2, x
being the smallest integer no less than x. Essentially we
are targeting the alternative that at least half of the studies
have non-zero effect sizes. Under our weighted ordered p-
values (WOP) framework, we are able to developmethods
for other hypothesis settings with r ranging from m + 1
to K . But in general we hope to provide a simple to use
method without having to put too much effort in select-
ing a particular r, and therefore we will focus mostly on
testing HSm. We will later show through data applications
that using our WOP methods for testing HSm provides
more robust results compared to using the rOP method
with different choices of r.
A framework for weighted ordered P-values (WOP)
methods
We first describe the general framework for the weighted
ordered p-values (WOP) methods. Suppose we have p-
values p1, p2, · · · , pK for testing the hypothesis of inter-
est for each of the K studies. Let p(1), p(2), · · · , p(K) be
the ordered p-values. Now consider a set of weights
w1,w2, · · · ,wK associated with the corresponding ordered
p-values. Summary statistics of weighted ordered p-values





As mentioned by previous authors, many traditional
p-value combination methods can be expressed in the
general form of T ′ = ∑Ki=1 w′iH(pi) (for example, see
Zaykin [17]). For instance, Stouffer’s Z-test takes H(·) to
be the inverse normal function, while Fisher’s method has
H(pi) = −2 log (pi). The difference between T ′ and T ,
albeit subtle in notation, is the essence of theWOP frame-
work. In the WOP framework, the weight wi is associated
with the ith ordered p-value p(i). In other words, the rank-
ing of a p-value in relation to the p-values from the other
studies determines its weighting. In traditional weighted
p-value combining methods, the weight assigned to a
p-value is associated with the characteristics of that par-
ticular study, be it the sample size, the effect size, or other
features.
Allowing the weights to depend on the ordering of
the p-values opens up a whole new area of considera-
tions when combining multiple p-values. We can consider
giving more weights to the p-values that are closer to
the center of the distribution of the p-values since they
might hold more credibility, and at the same time down-
weight the outlying p-values. For instance, if the entirety
of weights is placed on the rth ordered p-value, the statis-
tic reduces to the rOP method. However, using the WOP
framework, if we highly weight the rth ordered p-value
but still distribute some weight to the other p-values, the
method can be viewed as a more robust version of the rOP
method for testing HSr .
In this paper, we shall develop a few specific methods
under the WOP framework. We consider weights based
on the binomial distribution, which will be described in
more detail in the next section. As for the p-value com-
bining methods, we shall focus on Fisher’s method, with
HF(p(i)) = −2 log (p(i)), and Stouffer’s method, with
HZ(p(i)) = φ−1(1 − p(i)), φ(·) being the standard normal
distribution function.
Li and Ghosh BMC Bioinformatics 2014, 15:226 Page 4 of 12
http://www.biomedcentral.com/1471-2105/15/226
Binomial weights and half-binomial weights
In this section, we discuss two possible weighting schemes
for the WOP framework. We mainly consider testing the
alternative hypothesis that the effect sizes are non-zero
in the majority of studies, which is the hypothesis setting
HSm. We will also briefly discuss extending the weight-
ing schemes to testing other hypothesis settings HSr , for
m < r ≤ K .
Inspired by the rOPmethod, which uses the rth ordered
p-value for testing the hypothesis setting HSr , we con-
sider placing the highest weight on the median p-values
for testing HSm. This makes intuitive sense, since if a con-
sensus does exist among the studies, we have reason to
believe that the behavior of the majority of studies should
be best captured by the p-values that are closer to the cen-
ter of the distribution. Since we do not insist on non-zero
effect sizes for every single study, we consider down-
weighting the largest p-values among the studies. On the
other hand, p-value combining methods such as Fisher’s
method are known to be very sensitive to single extremely
small p-values, thus the smallest p-values should also be
down-weighted, to avoid a small number of extremely
small p-values biasing the results of the majority of stud-
ies. In summary, we would like our weighting scheme wi,
as a function of i, to reflect a unimodal shape, with the
highest weights being wm (when K is odd) or wm−1 and
wm (when K is even), and such that wi decreases as i goes
to 1 or K .
To reflect the above properties of the weights, we con-
structed the weights based on the binomial distribution.
Let f (x; n, p) be the probability mass function of the bino-
mial distribution B(n, p), for x = 0, 1, · · · , n. We define the
binomial weighting scheme such that
wbi = f (i − 1;K − 1, 0.5), i = 1, 2, · · · ,K .
In the binomial weighting scheme, all the weights are
non-zero, thus every p-value contributes to the combined
statistic. To further reduce the influence of the small-
est p-values on the summary statistic, we may argue that
only p(m), p(m+1), · · · , p(K) matters in testing the alter-
native that at least m studies have non-zero effect size.
With these considerations, we define what we call the
half-binomial weighting scheme such that
whbi =
{
0, i = 1, 2, · · · ,m − 1,
wbi , i = m,m + 1, · · · ,K .
We will discuss more on the effects of these two differ-
ent weighting schemes through simulation studies in later
sections.
So far we have constructed the binomial weighting
scheme and half-binomial weighting scheme for testing
the hypothesis setting HSm. We can extend the ideas of
these two weighting schemes to testing HSr , for m < r ≤
K . Instead of placing the highest weights on the medi-
ans, the highest weight can now be assigned to p(r). When
r = m, we lose the natural symmetry of the weights.
However, we can still base the weights on the binomial dis-
tribution. A few possible weighting schemes are defined
below:
wb1i =
{ 0, i = 1, · · · , r − m
wbi−(r−m), i = r − m + 1, · · · ,K .
wb2i = f (i − 1;K + 2(r − m) − 1, 0.5), i = 1, · · · ,K .
wb3i =
{
0, i = 1, · · · , 2(r − m)
f (i − 2(r − m) − 1;K − 2(r − m)−1, 0.5), i=2(r − m) + 1, · · · ,K .
The weighting scheme wb1 is based on the same bino-
mial distribution as wb, except that the values are shifted
so that the center of the distribution falls on r instead
of m. Because of the shift, the first few weights are set
to be 0, while the last few values in the probability mass
function of the binomial distribution are truncated. The
weighting scheme wb2 increases the parameter n to K +
2(r − m) − 1 in the binomial distribution to ensure that
the first few weights are non-zero. The weighting scheme
wb3 decreases the parameter n to K − 2(r − m) − 1 in
the binomial distribution so that the distribution is not
truncated on the right. See Figure 1 for an illustration of
the idea of these three weighting schemes. Corresponding
half-binomial weights for these three binomial weighting
schemes: whb1, whb2 and whb3, can be easily constructed
by setting the weights to be 0 for i = 1, · · · , r − 1.
Implementation of the WOPmethods
Under the null hypothesis, the pk ’s are assumed to fol-
low a uniform (0,1) distribution. For Stouffer’s Z-test,
HZ(pi) = φ−1(1 − pi) follows a standard normal distri-
bution. Therefore the traditional weighted Z-test in the
form of
∑K
i=1 w′iHZ(pi) still follows a normal distribution.
For Fisher’s method, HF(pi) = −2 log (pi) has a chi-
square distribution with two degrees of freedom. There-
fore the distribution of the traditional weighted Fisher’s
test
∑K
i=1 w′iHF(pi) is essentially weighted sums of expo-
nential distributions. The distribution of weighted sums
of exponential variables is not as straightforward, though
many authors have researched on both the exact and
approximations of this distribution, a summary of which
can be found in Olkin and Saner [10].
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Figure 1 Illustration of weighting schemes. Intuition behind the
three weighting schemes wb1, wb2 and wb3 form < r ≤ K . The plot
reflects an example of K = 9. The weighting scheme wb for testing
HS5 is plotted as a reference. The other three weighting schemes are
for testing HS7. From the plot we can easily see that wb1 is a direct
shift of wb , which is based on the distribution of B(8, 0.5). wb2 is based
on the distribution of B(12, 0.5), and wb3 is based on the distribution
of B(4, 0.5).
When we consider weighted ordered p-values in the
form of
∑K
i=1 wiH(p(i)), however, the problem becomes
much more complicated. Even for Stouffer’s method, the
distribution of the sum of weighted ordered normal vari-
ables is not readily available. As for Fisher’s method, Olkin
and Saner [10] studied the distribution of the trimmed
Fisher’s statistic, which is
∑K
i=1 −2wilog(p(i)) for the spe-
cial case of wi = 0 for i = 1, · · · , s1 and i = s2, · · · ,K .
They transformed the distribution of the sum of ordered
chi-squared variables back to a weighted sum of expo-
nential variables without order. But as discussed in their
paper, the exact distribution of weighted sums of expo-
nential variables are generally impractical for practition-
ers, and we would therefore have to use approximation
methods.
Considering the complexity of the exact distributions
of weighted sums of ordered variables, as well as the
fact that the uniformness of the original p-values is
not always guaranteed in practice, we recommend two
methods for obtaining the p-values for the WOP statis-
tics: (1) permutation analysis, in the case that original
data from all the studies are available; and (2) com-
paring to the numerical distribution, in the case that
only the p-values for each gene and each study are
known.
We first explain the steps of obtaining the WOP p-
values through permutation analysis:
(1) Let Tg =∑Ki=1 wiH(pg(i)) denote the WOP statistic
for gene g, where pg(i) is the ith ordered p-value of
pg1, · · · , pgK .
(2) Permute group labels in each study B times, and
recalculate the p-values for the permuted data p(b)gk ,
for 1 ≤ k ≤ K , 1 ≤ g ≤ G, 1 ≤ b ≤ B.
(3) Calculate the WOP statistics for the permuted
p-values T (b)g for 1 ≤ g ≤ G, 1 ≤ b ≤ B.






g′=1 I{Tg ≥ T (b)g′ }
B · G .
Once the p-values for the WOP statistics for each gene
are obtained, we may apply the Benjamini-Hochberg (BH)
method [18] on the pTg ’s (1 ≤ g ≤ G) to account for multi-
ple testing across the genes and control the false discovery
rate (FDR).
If the original data are not available, we can simu-
late the distribution of the WOP statistics numerically,
by simulating U(0, 1) random variables, the distribu-
tion of p-values under the null distribution. The WOP
statistics calculated from the data can then be com-
pared to the numerical distribution to obtain the WOP
p-values. We simulated numerical distributions of the
WOP statistics for testing HSm based on the Fisher’s
and Stouffer’s combination methods with binomial and
half-binomial weighting schemes respectively, for study
numbers ranging from 4 to 23. We conducted simu-
lation studies to compare the WOP p-values obtained
either though comparing with the numerical distribu-
tion or by performing permutation analysis. Results show
that the two methods provide perfectly correlated p-
values and that the number of rejections obtained from
the two methods after applying the Benjamini-Hochberg
adjustment are very similar (data not shown). There-
fore both methods are reliable choices for obtaining the
WOP p-values in practice. The numerical distribution
provides an option for when the original data are not
available and is also more time-efficient. The permuta-
tion analysis can be used if the uniformness of the original
p-values are questionable but that the original data is
available.
Considerations of one- or two-sided tests
Previously we used two-sided alternatives as an example
when setting up the hypothesis. The hypothesis setupHSr
can be similarly developed for one-sided alternatives. In
fact, the interpretation of the meta-analysis results is eas-
ier for one-sided tests, since we do not need to worry
about the concordance of the directions of the effect sizes
as we do for two-sided tests. Since the WOP methods
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directly combine the p-values, the direction of the effect
sizes are not taken into account for two-sided tests. Thus
a significant result from the WOP meta-analysis of two-
sided tests indicate that there are at least r studies with
non-zero effect size, but without any implications about
the concordance or discordance of the directions of the
effects. This may not be an issue in the case that the
direction of effect is not of great importance. However, in
genomic data analysis, it is often desirable to distinguish
between up- and down-regulated genes, and a result stat-
ing that the gene is differentially expressed across many
studies but with possible opposite directions of expres-
sion change may be confusing. In these cases, it might be
problematic to directly apply the WOP methods to the
two-sided p-values. On the other hand, since both up- and
down-regulated genes may be of interest at the same time,
we cannot pre-specify one particular one-sided test for all
genes. For such scenarios we recommend using the test of
Pearson [19] in combination with the WOP methods. To
do so, for each gene we need to conduct two WOP meta-
analyses on one-sided p-values: one on the left-tailed
p-values for all studies, and the other on the right-tailed
p-values for all studies. Let pLWOP and pRWOP be the WOP
meta-analysis p-values for the left-tailed and right-tailed
tests respectively. We shall then adopt the idea of Pear-
son’s test and define pCWOP = min{1, 2min(pLWOP , pRWOP)},
where the superscript “C” stands for “concordant”. As dis-
cussed in Owen [20], the equation for obtaining pCWOP
provides a conservative p-value for Pearson’s test. By
adopting the Pearson’s test, the results are more inter-
pretable. A significant result now indicates that the




We conducted a simulation study to compare the perfor-
mances of the WOP methods with the original Fisher’s
and Stouffer’s method, as well as with the rOP method
Song and Tseng [1]. We shall also demonstrate the differ-
ences between the binomial and half-binomial weighting
schemes through the simulation.
We simulate the setting of a meta-analysis of differen-
tial expression studies, with 2000 genes and 7 studies.
Out of the 2000 genes, 1650 genes are assumed to be not
differentially expressed in any study, while 50 genes are
assumed to be differentially expressed in 1, 2, · · · , 7 stud-
ies respectively. The sample sizes for the treatment and
control groups are randomly generated for each study,
varying from 5 to 20. Gene expression values are ran-
domly generated from normal distributions. Control sam-
ples are generated from a N(0, 1) distribution, as well as
treatment samples that are not differentially expressed.
Treatment samples that are differentially expressed are
generated from a N(1, 1) distribution. Two-sample T-
tests are used to obtain the p-values pgk for each gene
and each study. Our WOP methods aim at testing the
hypothesis that the gene is differentially expressed in the
majority of studies. In this case, m = 4, corresponding
to the hypothesis setting HS4. The rOP statistic Song and
Tseng [1] for testing HS4 is the 4th ordered p-value. Note
that the original Fisher’s and Stouffer’s method are sup-
posed to test for HS1. We used permutation analysis to
obtain the WOP p-values for binomial and half-binomial
weighted Fisher’s and Stouffer’s statistic. P-values for the
rOP method were also computed by permutation anal-
ysis as recommended in Song and Tseng [1]. P-values
for the original Fisher’s and Stouffer’s method are com-
puted directly via their respective distributions. To obtain
a list of significant genes, the Benjamini-Hochberg pro-
cedure is applied to the p-values with the FDR con-
trolled at the 0.05 level. Results are averaged over 100
replications.
Figure 2 compares the power of the methods for differ-
ent categories of genes. Genes are categorized based on
the number of studies that they are differentially expressed
in (0 to 7). The proportion of genes rejected within each
category are plotted for the different methods. Before
we compare the methods, it is important to note that
the reading of these plots may be different from tradi-
tional power plots. Normally when looking at a power
plot, the higher the power the better. In our case, how-
ever, this is not true for all categories. Remember that
our goal is to focus on a particular subset of the non-
null space - genes that are differentially expressed in at
least 4 studies. Therefore, all non-null genes are not cre-
ated equal. In particular, rejections of genes in categories
4 through 7 are desirable, whereas rejections of genes in
categories 1 through 3 are undesirable. Rejections of genes
in category 0 are of course considered false discoveries.
As expected, regardless of the method, the proportion
of genes rejected within a category increases from 0 to
close to 1 as the number of studies that the genes are dif-
ferentially expressed in increases from 0 to 7 (out of 7).
Fisher’s method, being a very powerful method for test-
ingHS1, has the highest proportion of rejections for every
category from 1 to 7. Stouffer’s method also has the
highest proportion of rejections when compared to the
corresponding weighted versions and the rOP method.
However, as mentioned earlier, rejections in categories 0
to 3 are considered undesirable when testing HS4. Both
the WOP methods and the rOP method reject much
smaller proportions of genes in categories 1 to 3 com-
pared to the original Fisher’s or Stouffer’s method. Less
rejections in categories 1 to 3 come at the expense of
less power for categories 4 to 7, which is true for both
WOP and rOP methods, but particularly so for the rOP
method. For the binomial weighted WOP methods, the
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Figure 2 Comparison of power. Power comparison for the different methods. The x-axis denotes the 8 categories of genes, categorized by the
number of studies that the genes are differentially expressed in. There are 1650 genes in the category 0 (no differential expression in any studies).
The rest of the categories contain 50 genes each. For each category, the proportion of genes found significant within that category are plotted for
each method.
rejections for categories 1 to 3 are much lower compared
to Fisher’s or Stouffer’s method, but the power for cate-
gories 4 to 7 gradually increases to catch up with Fisher’s
or Stouffer’s. When it comes to categories 6 and 7, espe-
cially category 7, the binomial weighted WOP methods
have virtually the same power as Fisher’s and Stouf-
fer’s. On the other hand, the rOP method has the lowest
power for categories 6 and 7, which are the genes that
are differentially expressed in all or almost all the stud-
ies. The half-binomial weighted WOP methods have the
lowest rejection rates for categories 1 to 3, even lower
than the rOP method, but their power surpasses the
power of the rOP method when it comes to categories
6 and 7.
To better look at the trade off between rejection rates for
categories 0 to 3 versus categories 4 to 7, we plotted the
ROC curves for themethods, as seen in Figure 3. Since our
goal is to test for HS4, we treat rejections in categories 0
to 3 to be false positives, while rejections in categories 4 to
7 are considered true positives. From the ROC curves we
can clearly see that in terms of the trade off between true
and false positives the binomial weighted WOP meth-
ods beat the original Fisher’s or Stouffer’s method, while
the half-binomial weighted WOP methods beat the rOP
method. We also gain better insight into the compari-
son between the binomial and half-binomial weighting
schemes. The half-binomial weighting scheme is relatively
more conservative, with relatively higher true positive
rates at very low false positive rates. On the other hand,
the binomial weighting scheme achieves higher power
when slightly higher false positive rates are allowed.
In summary, the binomial weighted WOP methods
show improvement over the original Fisher’s or Stouffer’s
method for testing differential expression in a majority of
studies, with lower rejection rates for genes that are dif-
ferentially expressed in a small number of studies, and just
as high power for genes that are differentially expressed
in almost all studies. On the other hand, the half-binomial
weighted WOP methods are more robust versions of
the rOP method, having similar properties to the rOP
method, but even lower rejections rates for categories 1 to
3 and higher power for categories 6 and 7. In practice, the
binomial weighting scheme is recommended if the user
wishes to have a larger pool of significant genes, and when
the control of false positives is relatively less important.
For better false positive control, the half-binomial weight-
ing scheme is recommended. We note that because of our
hypothesis setup, false positives are not the same as type
I error. A type I error would be rejecting a gene that is
not differentially expressed in any studies. On the other
hand, a false positive would be rejecting a gene that is
differentially expressed in less than r studies.
An application to meta-analysis of a set of stem cell studies
As an application of the proposed methodology, we con-
duct meta-analysis on a set of microarray data studies
from four stem cell papers: Chin et al. [21], Guenther
et al. [22], Newman and Cooper [23] and Chin et al. [24].
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Figure 3 ROC curves. ROC curves for the different methods. Rejections of genes differentially expressed in less than 4 studies are considered false
positives. Rejections of genes differentially expressed in 4 or more studies are consider true positives.
We wish to find probesets that are differentially expressed
between human induced pluripotent stem (hiPS) cells
and human embryonic stem (hES) cells in the majority
of studies. Some of the studies contain other samples
such as human fibroblasts, but we only used samples
from hiPS cells and hES cells. We included studies that
had at least two samples for each group (hiPS and hES),
giving us a total of 9 studies. All the studies used the
Affymetrix Human Genome U133 Plus 2.0 Array plat-
form, which contains 54675 probesets. We directly used
the data preprocessed by the original contributors and did
not perform any additional normalization, except for tak-
ing the log for data that were not already on the log2 scale.
We performed a two sample T-test between the hiPS cell
samples and the hES cell samples to obtain the original
p-values for differential expression for each probeset and
each study. The hypothesis setting for the meta-analysis is
HS5, i.e. we aim at testing the alternative that the probe-
set is differentially expressed in at least 5 out of the 9
studies. We applied the proposed WOP methods, in par-
ticular the binomial and half-binomial weighted Fisher’s
and Stouffer’s statistic to the p-values. The p-values for
the WOP statistics are obtained by comparing the statis-
tics to the corresponding numerical distributions. We
also applied the original Fisher’s and Stouffer’s method,
and the rOP method (in this case the 5th ordered p-
value). The p-values for the rOP method are obtained
via its theoretical distribution. To adjust for multiple test-
ing, we applied the Benjamini-Hochberg (1995) proce-
dure afterwards, controlling the false discovery rate at the
0.05 level.
The number of probesets significant for the meta-
analysis using the different methods are summarized in
Table 1. The original Fisher’s and Stouffer’s methods
found the most number of significant probesets. It is likely
that they picked out many probesets that are differen-
tially expressed in a few, but less than half the studies.
The half-binomial weighted WOP methods and the rOP
method are relatively more conservative and focused.
Figure 4 shows a Venn diagram of the probesets found
significant by the binomial and half-binomial weighted
Fisher’s method and the rOP method. We can see that
the probesets detected by both the half-binomial weighted
Fisher’s method and the rOP method are mostly detected
by the binomial weighted Fisher’s method as well. How-
ever, there are still a number of unique probesets that
are only detected by either the half-binomial weighted
Fisher’s method or the rOP method. To get an idea of
the types of probesets detected by only one of the three
aforementioned methods, we randomly selected some of
these probesets and plotted the ordered original p-values
from the 9 studies for these probesets. As seen in Figure 5,
probesets exclusively detected by the binomial weighted
Table 1 Number of significant probesets for the
meta-analysis of stem cell studies by different methods
Method Fisher’s Stouffer’s rOP
Original (unweighted) 16508 11969 6330
WOP: Binomial weighted 10309 8927 N/A
WOP: Half-binomial weighted 6170 5805 N/A











Figure 4 Venn diagram for stem cell studies. Venn diagram for the
probesets found significant by the binomial weighted Fisher’s
method, the half-binomial weighted Fisher’s method and the rOP
method.
Fisher’s method tend to have very small values for the
two or three smallest p-values, but relatively larger values
starting the 5th ordered p-value. This shows that the bino-
mial weighted Fisher’s method is more prone to influences
by the smallest p-values, since it takes into account all the
p-values in the statistics. The rOP method, which uses






















Binomial weighted Fisher only
Half-binomial weighted Fisher only
Figure 5 P-value patterns for different methods. Pattern of the
original ordered p-values from the 9 studies for probesets detected
by one of the three methods only. The x-axis is the order of the
p-values from the 9 studies. The y-axis is the p-values. The plot
includes a random subset of 20 probesets that are detected
exclusively by each of the three methods.
the 5th ordered p-value as the statistic, exclusively identi-
fies probesets that are guaranteed to have relatively small
p-values up to the 5th ordered p-value, but tend to have
very large values starting the 6th ordered p-value. This
shows the sensitivity of the rOP method to the particular
value of r chosen. On the other hand, the half-binomial
weighted Fisher’s method weights in the 5th through the
9th ordered p-values, and thus is able to identify probesets
that have relatively small values through larger ordered p-
values. In other words, probesets that have relatively small
p-values for most of the studies can be exclusively iden-
tified by the half-binomial weighted method, even if the
smallest p-values are not very small.
To look at the pathways associated with the signifi-
cant lists of probesets, we performed functional annota-
tion clustering analysis using DAVID (Huang et al, 2009),
which is available at http://david.abcc.ncifcrf.gov/home.
jsp. Some of the top functions that show up include metal-
binding, nucleoplasm, ubl conjugation, vasculature devel-
opment and head/face development.We also looked at the
pathways for the probesets that were exclusively detected
by one of the methods. Functions such as neuron projec-
tion, neuron differentiation and development, which are
meaningful in the stem cell study setting, were found to
be associated with the probesets exclusively identified by
the half-binomial weighted Fisher’s method. These func-
tions did not show up in pathway analyses of the other
lists.
Further applications and comparisonswith the rOPmethod
To compare the performances of the WOP methods
and the rOP method Song and Tseng [1] in real data
application, we applied our WOP methods to the three
microarray meta-analysis applications in Song and Tseng
[1]. The first application consists of comparisons of
two subtypes of brain tumors - anaplastic astrocytoma
(AA) and glioblastoma multiforme (GBM), from 7 stud-
ies. The second application combines 9 studies compar-
ing post-mortem brain tissues between MDD patients
and control samples. In the third application, 16 dia-
betes microarray studies consisting of different organisms
and tissues were combined. See Song and Tseng [1] for
more details on the contexts of these three meta-analysis
applications.
To ensure that the results are directly comparable, for
each meta-analysis we directly used the two-sided p-
values for each gene and each individual study calculated
in Song and Tseng [1]. In Song and Tseng [1], permuta-
tion analysis is used for the brain cancer studies and the
MDD studies, while theoretical distributions are used to
obtain results for the diabetes studies.We follow Song and
Tseng [1] and also directly use the two-sided p-values for
the permuted datasets provided by Song and Tseng [1] for
the brain cancer studies and the MDD studies. See Song
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and Tseng [1] for more details on the preprocessing of the
data and the calculation of the original p-values.
We applied our WOP methods, namely the binomial
and half-binomial weighted Fisher’s and Stouffer’s statis-
tic, to the three sets of studies. For the brain cancer
studies, we test for HS4 out of 7 studies. For the MDD
studies we test for HS5 out of 9 studies. For the dia-
betes studies, we test for HS9 out of 16 studies. We also
applied the corresponding rOP methods for testing the
same hypotheses, using r = m = 4, 5 and 9 respec-
tively for the three meta-analyses. In addition, we applied
the rOP methods using the selected r values in Song and
Tseng [1] for comparison. To be specific, Song and Tseng
[1] used r = 5 for the brain cancer studies, r = 7 for
the MDD studies, and r = 12 for the diabetes studies.
Permutation analysis is used for the brain cancer studies
and the MDD studies for all methods. For the diabetes
studies, we used our numerically simulated distribution to
obtain the p-values for the WOP statistics. Table 2 shows
the numbers of significant genes found using the different
methods for the three meta-analyses with the FDR con-
trolled at the 0.05 level. We can observe that the WOP
methods using the binomial weighting scheme gener-
ally detects more significant genes than the half-binomial
weighting scheme. In most cases, the rOP methods (using
either r = m or selected r) detect less genes than the
WOP methods, although in general closer in number
to the WOP methods using the half-binomial weighting
scheme.
One interesting observation is that for the MDD stud-
ies, the rOP method based on r = m = 5 detects less
genes than based on the selected r = 7. This result is
counterintuitive, since one would expect that genes that
are differentially expressed in at least 7 studies would be
a subset of the genes that are differentially expressed in at
least 5 studies. The result could be due to the fact that r
is selected in Song and Tseng [1] to optimize the number
of significant genes and therefore outperforms a general
choice of r = m. Nonetheless, this reflects the fact that
the rOP method is sensitive to the choice of r. To further
investigate this problem, we looked at the overlap of the
detected genes by the rOP methods using either r = m
or selected r, as well as with the detected genes by the










Figure 6 Venn diagram for MDD studies. Venn diagram for the
genes found significant in the meta-analysis of the MDD studies by
the rOP method based on r = m, the rOP method based on selected
r, and the half binomial weighted Fisher’s method. In this case,m = 5
and the selected r = 7.
a Venn diagram of the genes detected by the aforemen-
tioned three methods for the MDD studies. As shown in
Figure 6, only 269 genes overlap between the rOP meth-
ods with two different choices of r, which is less than half
of the genes detected by either method. However, all 269
genes are detected by the half-binomial weighted Fisher’s
method. In addition, the WOP method also picked up
251 of the genes only detected by rOP based on selected
r and 239 of the genes only detected by rOP based on
r = m, which accounts for most of the genes detected
by either method. Further, we noticed that even for the
brain cancer studies and the diabetes studies, where rOP
based on r = m did detect more genes than rOP based on
selected r, there are still a large number of genes detected
by rOP based on selected r that are not detected by rOP
based on r = m. On the other hand, most of these
genes that are detected by only one of the rOP meth-
ods are detected by the half-binomial weighted Fisher’s
method.
Table 2 Number of significant genes for the threemeta-analyses by different methods
WOP Fisher WOP Fisher WOP Stouffer WOP Stouffer rOP rOP
binomial half-binomial binomial half-binomial r = m selected r*
Brain Cancer 2477 1887 2261 1805 1921 1469
MDD 1070 930 1152 969 565 617
Diabetes 1333 1016 1277 1004 912 636
*For the rOP method, “selected r” refers to the choice of r in Song and Tseng [1] for a particular meta-analysis.
Li and Ghosh BMC Bioinformatics 2014, 15:226 Page 11 of 12
http://www.biomedcentral.com/1471-2105/15/226
For comparison, to see how the results would differ for
different choices of r for the WOP methods, we applied
the WOP method to the MDD studies again - this time
testing HS7. We used the half-binomial versions of the
three weighting schemes for m < r ≤ K that were dis-
cussed earlier: whb1, whb2 and whb3. We used Fisher’s
summary statistic in the WOP method. The numbers of
genes found by using the three weighting schemes are 760,
770 and 774 respectively. The three weighting schemes are
fairly consistent with each other, since for each weight-
ing scheme more than 90% of the genes found were also
found by the other two weighting schemes. Comparing to
the number of genes found by the half-binomial weighted
Fisher’s method for testing HS5, which is 930, notice that
the corresponding WOP methods for testing HS7 yield
smaller numbers, conforming to our expectations. As dis-
cussed earlier, the ideal result would be that the genes
detected for HS7 be a subset of the genes detected for
HS5. In reality, over 70% of the genes detected by WOP
methods for HS7 were also detected for HS5 (the percent-
age being 72.6%, 71.4% and 74.2% for the three weighting
schemes respectively). Recall that for the rOP method,
only 43.6% of genes detected for r = 7 were also detected
for r = 5. Even though the WOP methods are not per-
fect, we can still see the great improvement in robustness
compared to the rOP method.
In summary, our observations confirm that the results
of the rOP method are indeed heavily dependent on the
choice of r. Whereas our WOP methods show much
higher robustness. In particular, the WOP methods for
testing HSm has shown superior robustness by being able
to cover most of the genes detected by the rOP meth-
ods using different r. Since in practice it is not often clear
which particular HSr should be tested, we believe the
WOPmethods for testingHSm is a better choice when the
goal is to detect signal in the majority of studies.
Conclusions
Meta-analysis is a useful tool in integrating data from dif-
ferent sources to test a particular hypothesis. While this
paper mainly discussed the application of meta-analysis
on microarray differential expression studies, other areas
of genomic studies have increasingly relied on the use
of meta-analysis, such as genome-wide association stud-
ies (GWAS). Some seminal studies in this area include
Scott et al. [25] and Willer et al. [26]. Meta-analysis is also
frequently used in clinical studies, psychological studies
and statistical applications in other social sciences. More
and more meta-analyses nowadays aim at detecting con-
sistent findings across a number of studies. While most
of the traditional meta-analysis methods test for signif-
icance in at least one of the studies, it is important to
develop new meta-analysis methods that focus on testing
for significance in the majority of studies.
The weighted ordered p-value (WOP) method provides
such a framework. It is unique in its use of weights that
are based on the order of the p-values. The rOP method
Song and Tseng [1], which is also based on ordered p-
values, can be considered a very special case under the
WOP framework, where all the weight is placed on one
single ordered p-value. TheWOPmethods do not require
pre-specification of r and is less sensitive to the choice of
its value. The half-binomial weightedWOPmethods have
been shown to be more robust and have better receiver
operating characteristics compared to the corresponding
rOP method.
As pointed out by a reviewer, one of our previously pub-
lished meta-analysis methods also considers the issue of
heterogeneity and utilizes weights. However, these two
methods are quite different in concept. The method in [9]
applies weights to the genes, essentially to re-rank the
genes by adding in information about heterogeneity. On
the other hand, the WOP method applies weights to the
multiple p-values for each gene. Although, conceptually,
we can first apply theWOPmethod to each gene and then
use the method in [9] on top of that to re-rank the genes.
One advantage of the WOP framework is its flexibil-
ity. The framework allows for different weighting schemes
and summary statistics to be used. Even though this paper
mainly focused on two particular weighting schemes
based on the binomial distribution and two summary
statistics (Fisher’s and Stouffer’s statistics), in general,
other summary statistics and weighting schemes can be
used. Future research can be done to try to optimize the
weighting scheme to suit specific meta-analysis purposes.
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